VMP 42184311000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Antazoline 0.5% / Xylometazoline 0.05% eye drops
BNF code 1104020B0AAACAC
Virtual Therapeutic Moiety Antazoline + Xylometazoline
Date identifier became valid 25 Aug 2023
Previous product identifier 330427006
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Continuous
Virtual Product Ingredient
Ingredient Antazoline sulfate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 5.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Virtual Product Ingredient
Ingredient Xylometazoline hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 500.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutiondrops.ophthalmic
Dose Form
Formulation Eye drops
Drug Route
Route Ocular
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Otrivine Antistin 0.5%/0.05% eye drops (Thea Pharmaceuticals Ltd)
Virtual Medicinal Product Packs
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback